Rifamycin sodium
- Level
- Commodity
- Parent
- 51283600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51283611This classification denotes an antitubercular agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32086GS35Z. European Medicines Agency schedules Rifamycin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04246MIG. Rifamycin sodium generally arises in the molecular formula C37H46NO12.NA. The term 'rifamycin sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rifamycin sodium under HS 29419000 and SITC 54139. As of Q4 2014, RIFAMYCIN SODIUM remains US FDA's Preferred Term for this commodity. Rifamycin sodium bears US NLM identifiers UMLS ID C0771754 and NCI Concept Code C95605. SMILES: CC1C(C2C3C(CC(C2O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]([C@H](/C=C/O[C@@]4(C(=O)C3C1O4)C)OC)C)OC(=O)C)C)O)C)O)C)/C)[O-])O.[NA+].
Same parent
Under 51283600 · 12Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.